spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  HSV 

 HSMN NewsFeed - 31 Dec 2020
ImmVira Announces Series C Financing with Leading Specialist Investors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 10 Jan 2020
Candel Therapeutics Appoints Sandra E. Poole as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Sep 2019
Valo Therapeutics Acquires PeptiENV Technology from the University of Helsinki
Biopharmaceuticals Drug Delivery Oncology Acquisitions
 HSMN NewsFeed - 13 Feb 2019
Bausch & Lomb Receives 510(k) Clearance For Use Of The Tangible(R) Hydra-PEG(R) Custom Contact Lens Coating Technology On Several Of Its Boston(R) Gas Permeable Lens Materials And Zenlens(TM) Family Of Scleral Lenses
Devices Ophthalmology FDA
 HSMN NewsFeed - 23 Oct 2018
BioGX Launches 5 new CE Mark IVD Tests, Expands Sexual Health Panels on the BD MAX(TM)
Diagnostics Regulatory Product Launch
 HSMN NewsFeed - 24 May 2018
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
Diagnostics Product Launch
 HSMN NewsFeed - 25 Jan 2018
Aptima(R) HBV Quant Assay for Quantitation of Hepatitis B Viral Load Receives PMA Approval
Diagnostics FDA
 HSMN NewsFeed - 20 Jun 2017
Hologic Announces FDA Clearance of Aptima(R) Assay to Detect Herpes Simplex Virus 1 & 2
Diagnostics FDA
 HSMN NewsFeed - 28 Apr 2017
Sorrento Therapeutics Announces Closing of its Acquisition of Virttu Biologics
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 11 Nov 2016
OncBioMune Broadens Portfolio, Partners and Product with Vitel Acquisition
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2016
Roche Receives 510(K) Clearance from FDA for Treponema Pallidum Assay to Aid Clinicians in the Diagnosis of Syphilis Infection
Diagnostics FDA
 HSMN NewsFeed - 18 Dec 2015
European Commission Approves Amgen's IMLYGIC(TM) (talimogene laherparepvec) As First Oncolytic Immunotherapy In Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Oct 2015
Luminex Corporation Receives FDA Clearance for ARIES(R) System and ARIES(R) HSV 1&2 Assay
Diagnostics FDA
 HSMN NewsFeed - 7 Jul 2015
Theranos Receives First FDA Clearance for Finger Stick and Venous Blood Test and Independent FDA Review and Validation of its Underlying Theranos System for Herpes Simplex Virus-1 Diagnosis
Diagnostics FDA
 HSMN NewsFeed - 7 Aug 2014
Specialty Vaccine Company PaxVax Expands Global Commercial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2014
Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test for Group A Strep
Diagnostics FDA
 HSMN NewsFeed - 21 Jun 2013
3-V Biosciences Completes $20 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Nov 2012
NanoBio(R) Closes $11 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Oct 2012
Genocea Closes $30 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Sep 2012
GenVec Announces Reduction in Workforce
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2012
GenVec Appoints Cynthia Collins as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2011
GenVec President and Chief Executive Officer Announces Retirement
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Dec 2010
BioVex Commences OncoVEXGM-CSF Phase 3 Trial in Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Sep 2010
Predictive Biosciences Appoints New Members to Leadership Team
Diagnostics Oncology Urology Personnel
 HSMN NewsFeed - 1 Jul 2010
BioVex Appoints Steven Kelly as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2010
Bausch & Lomb Acquires Zirgan(R) (Ganciclovir Ophthalmic Gel 0.15%) From Sirion Therapeutics for the Treatment of Herpetic Keratitis
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 19 May 2010
GenVec Announces Resignation of Mark Thornton as Senior Vice President, Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Feb 2010
Medivir partners with Meda to commercialize Xerese(TM) (Lipsovir(R)) in North America
Biopharmaceuticals
 HSMN NewsFeed - 27 Jan 2010
Juvaris BioTherapeutics Completes Second Close on $25 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Jan 2010
BioVex Appoints Tim Hanke as VP Commercial Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Sep 2009
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Sep 2009
Sirion Therapeutics Announces FDA Approval of Zirgan(TM) (Ganciclovir Ophthalmic Gel) 0.15% for Herpetic Keratitis
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 24 Jul 2009
FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business
Diagnostics FDA
 HSMN NewsFeed - 22 Jul 2009
Profectus Biosciences Secures $5M in Series C Venture Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Mar 2009
BioVex Raises $40 Million in First Close of Series F Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 24 Mar 2009
Epiphany Biosciences Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Jan 2009
Sirion Therapeutics New Drug Application for Ganciclovir is Accepted for Review by the FDA for the Treatment of Ocular Herpes
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 21 Jan 2009
Alnylam and Collaborators at Harvard Medical School Demonstrate In Vivo Silencing of Key Genes Implicated in the Transmission of Herpes Simplex Virus-2 (HSV-2)
Biopharmaceuticals
 HSMN NewsFeed - 11 Nov 2008
TNFerade(TM) Receives FDA Fast Track Designation for Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Jun 2008
BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Nov 2007
BioVex Closes Second Round of Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Nov 2007
Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
Diagnostics FDA
 HSMN NewsFeed - 25 Oct 2007
BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2007
BioVex Appoints Dr. Leonard Post to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Aug 2007
BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2007
BioVex Raises $22 Million in First Close of Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Mar 2007
Focus Diagnostics Receives FDA Clearance to Market Plexus HerpeSelect
Diagnostics FDA
 HSMN NewsFeed - 15 Feb 2007
Cepheid Acquires Sangtec Molecular Diagnostics AB
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 9 Oct 2006
Pfizer Expands Commitment to Fight Infectious Diseases With Agreement to Acquire Vaccine Company PowderMed Ltd
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 22

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 22 additional stories matching:
HSV
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!